New Horizons in Myeloproliferative Neoplasms Treatment: A Review of Current and Future Therapeutic Options
Philadelphia-negative myeloproliferative neoplasms (MPN) are aggressive diseases characterized by clonal proliferation of myeloid stem cells. The clonal process leads to excessive red cells production, platelets production, and bone marrow fibrosis. According to the phenotype, MPN can be classified...
Enregistré dans:
Auteur principal: | Domenico Penna |
---|---|
Format: | article |
Langue: | EN |
Publié: |
MDPI AG
2021
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/61c8db4b2543475f9aad70a2daa5087c |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
Ruxolitinib: a targeted treatment option for patients with polycythemia vera
par: Vaddi K, et autres
Publié: (2016) -
Disseminated tuberculosis with myelofibrosis presentation: a case report
par: Mahdi Khatuni, et autres
Publié: (2021) -
Molecular Progression of Myeloproliferative and Myelodysplastic/Myeloproliferative Neoplasms: A Study on Sequential Bone Marrow Biopsies
par: Magdalena M. Brune, et autres
Publié: (2021) -
Polycythemia Vera (PV): Update on Emerging Treatment Options
par: Benevolo G, et autres
Publié: (2021) -
The Classification of Myeloproliferative Neoplasms: Rationale, Historical Background and Future Perspectives with Focus on Unclassifiable Cases
par: Marco Pizzi, et autres
Publié: (2021)